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Abstract 
Developmental brain disorders, a highly heterogeneous group of disorders with a prevalence of around 3% of 
worldwide population, represent a growing medical challenge. They are characterized by impaired neurodevel-
opmental processes leading to deficits in cognition, social interaction, behavior and motor functioning as a 
result of abnormal development of brain. This can include developmental brain dysfunction, which can mani-
fest as neuropsychiatric problems or impaired motor function, learning, language or non-verbal communica-
tion. Several of these phenotypes can often co-exist in the same patient and characterize the same disorder. 
Here I discuss some contributions in 2019 that are shaking our basic understanding of the pathogenesis of neu-
rodevelopmental disorders. Recent developments in sophisticated in-utero imaging diagnostic tools have raised 
the possibility of imaging the fetal human brain growth, providing insights into the developing anatomy and 
improving diagnostics but also allowing a better understanding of antenatal pathology. On the other hand, 
advances in our understanding of the pathogenetic mechanisms reveal a remarkably complex molecular neu-
ropathology involving a myriad of genetic architectures and regulatory elements that will help establish more 
rigorous genotype-phenotype correlations. 
Keywords: in utero diffusion magnetic resonance imaging, in utero diffusion tensor imaging, RNA editing, Retrotransposons, Brain 
organoids, Single cell omics 
 
Abbreviations 
3D - three-dimensional, ADAR - adenosine deami-
nase acting on RNA, ASD - autism spectrum disorder, 
ADHD - attention deficit hyperactivity disorder, CA3 - 
Cornu Ammonis area 3, CEN - Central Executive Net-
work, CNS - central nervous system, CNVs - copy number 
variations, DG - dentate gyrus, DLPFC - dorsolateral 
prefrontal cortex, DMN - Default Mode Network, DSM - 
The Diagnostic and Statistical Manual of Mental Disor-
ders, DTI - diffusion tensor imaging, edQTL - editing 
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quantitative trait loci, EEG - electroencephalography, FA 
- fractional anisotropy, FXS - Fragile X syndrome, GABA - 
γ-aminobutyric acid, GO - gene ontology, GWAS - ge-
nome-wide association study, HERV - human endoge-
nous retroviruses, hPSCs - human pluripotent stem cells, 
hESCs - human embryonic stem cells, hiPSCs - human 
induced pluripotent stem cells, iPSCs - induced pluripo-
tent stem cells, L1Hs - human-specific LINE-1, LINE-1 - 
long-interspersed nuclear element-1, MPFC - medial 
prefrontal cortex, MRI - magnetic resonance imaging, 
PGC - Psychiatric Genomics Consortium, rs-fMRI - rest-
ing-state functional MRI, scRNA-seq - single-cell RNA-
sequencing, snRNA-seq - single-nucleus RNA-
sequencing, TBSS - tract-based spatial statistics, TEs - 
transposable elements, TSA - tract-specific analysis 
Introduction 
Human brain structural and functional develop-
ment occurs over a protracted period compared to many 
other mammals and primates (Watson et al., 2006). This 
coordinated development provides the architecture for 
the expansion of behavioral and cognitive abilities, espe-
cially rapid in the first years, but also especially vulnera-
ble to genetic and/or environmental insults leading to 
developmental brain disorders. Classically those include 
intellectual disability, autism spectrum disorder (ASD), 
attention deficit hyperactivity disorder (ADHD), specific 
learning disorder, motor disorder, or epilepsy. However, 
beyond the traditional concept of neurodevelopmental 
disorders, studies in humans provide clear evidence that 
mental disorders such as schizophrenia, drug abuse, or 
neurodegenerative disorders such as Alzheimer’s dis-
ease also have a strong developmental component that 
might be identified by specific neuropathological fea-
tures (Thibaut, 2018). Understanding the role that de-
velopment plays in the expression of these disorders is 
often overlooked, but definitively needs more attention 
to fully understand the impact of early life events on the 
complex neurobiological derangement. 
From the clinical point of view, there has been a 
recent move at the diagnostic level from a categorical 
toward a spectrum-based view. For example, the defini-
tion of autism has been highly debated, in several revi-
sions of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM; DSM-III, DSM-IIIR, DSM-IV, and DSM-V) 
criteria (Rodgaard et al., 2019). This has led to a steady 
increase in the heterogeneity of some conditions which 
could affect the results of autism research. The recent 
advances in genomic medicine and the development of 
improved cellular models, will certainly help overcome 
these difficulties. 
On the mechanistic side, advances in directed dif-
ferentiation of human induced pluripotent stem cells 
(hiPSCs) and other neural cell preparations (van den 
Ameele et al., 2014), coupled with the application of 
advanced histological, imaging, molecular, cellular, and 
genomic techniques, is providing insights into cellular 
and molecular processes in human neurodevelopmental 
disorders and also in a wide array of neurological and 
psychiatric disorders (Brennand et al., 2011; Lancaster et 
al., 2013; Mariani et al., 2015; Pasca et al., 2015). 
Moreover, the recent advancements in single cell 
functional genomic techniques have enabled compre-
hensive and unbiased characterization of the molecular 
processes in human postmortem CNS tissues and neural 
cell culture systems, and will allow us to explore neuro-
developmental neuropathology at a resolution that was 
not possible before. Even so, our understanding of the 
spatiotemporal landscape of the RNA species, and epi-
genetic features in the developing human brain, and 
their pathogenicity is still incomplete (Qureshi & Mehler, 
2012). Finally, some findings suggest common patho-
physiological mechanisms that can be considered as a 
continuum of developmental brain dysfunctions. These 
findings revealed molecular pathways that are common-
ly altered in different forms of developmental brain 
disorders, both of genetic and environmental origin and 
new players are starting to be recognized such as ge-
nomic regulatory elements. 
1. Understanding neurodevelopmen-
tal disorders through imaging the 
prenatal brain 
One of the most crucial questions in neurodevel-
opmental disorders is what we can really detect from 
the wide range of developmental processes that take 
place (and can go wrong) during this critical period, and 
the extremely rapid pace of structural and functional 
brain development (Geng et al., 2017). The dynamic 
morphological changes the fetal brain undergoes during 
early development result from neurogenic events, such 
as neuronal proliferation, migration, axonal elongation, 
retraction, and myelination. In the critically sensitive 
mid-gestational phase of development, structural and 
functional assessment of the fetal brain opens a window 
into prenatal diagnostics and prognostics, and would 
help establish biomarkers for prenatal diagnoses (Batalle 
et al., 2017). Conventional T1 and T2 weighted sequenc-
es provide anatomic detail of the normally developing 
brain and can demonstrate lesions, including those asso-
ciated with preterm birth, hypoxic ischemic encephalo-
pathy, perinatal arterial stroke, infections, and congeni-
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tal malformations. Specialized imaging techniques can 
also be used to assess cerebral vasculature (magnetic 
resonance angiography and venography), cerebral me-
tabolism (magnetic resonance spectroscopy), cerebral 
perfusion (arterial spin labeling), and function (function-
al magnetic resonance imaging [MRI]) (Counsell et al., 
2019). Recent advances in in utero diffusion MRI provide 
unique opportunities to noninvasively study the micro-
structure of tissue during neurodevelopment and possi-
ble mechanisms of how pathologies, maternal, or envi-
ronmental factors that may interfere with brain devel-
opment can be potentially detected. One important 
aspect is that postmortem histologic studies of early 
childhood cortical development are consistent with 
imaging studies and provide insights into the neurobio-
logical process that underlie change observed in imaging 
studies (Christiaens et al., 2019). 
Abnormalities in processes, such as white matter 
and cortical connectivity in preterm babies have already 
been suggested to derive into late language develop-
ment and impaired cognitive performance in children. In 
utero diffusion tensor imaging (DTI) provides new win-
dows to monitor the emergence of the connectome. 
These advances have led to emerging fields of research, 
such as developmental pathoconnectomics (Jakab, 2019) 
that aim to unravel the development of disrupted brain 
connectivity. 
A wealth of quantitative tools, most of which were 
originally developed for the adult brain, can be applied 
to study the developing brain in utero and postnatally 
including measures of tissue microstructure obtained 
from diffusion MRI, morphometric studies to measure 
whole brain and regional tissue volumes, and automated 
approaches to study cortical folding. However, the dif-
ferences in functional organization between the brains 
of infants and adults call for infant-specific functional 
atlases for better definition of regions of interest and 
interpretation of results. Thus, the creation of resources 
such as a DTI atlas of the fetal brain is required for relia-
ble detection of major neuronal fiber bundle pathways 
and for characterization of the fetal brain reorganization 
in utero. Such tools are also useful for detection of nor-
mal and abnormal fetal brain development providing 
normative quantitative and qualitative data. The paper 
by Khan et al. (Khan et al., 2019) presents the first DTI 
atlas of the fetal brain computed from in utero diffusion-
weighted images. It was built from 67 fetal DTI scans 
acquired from healthy fetuses each scanned at a gesta-
tional age between 21 and 39 weeks, addressing a wider 
gestational age range and larger number of sampled 
areas than prior studies. The atlas computation method 
represents the first comprehensive approach to com-
pute motion-robust diffusion tensor maps from noisy in 
utero fetal measurements and combine individual DTI 
maps into a kernel-regressed template at any given 
gestational age which would enable statistical voxel-wise 
analysis, tract-based spatial statistics (TBSS), or tract-
specific analysis (TSA) based on DTI data (Pecheva et al., 
2017; Khan et al., 2018). The neurodevelopmental 
trends characterized by the atlas in the fetal brain were 
qualitatively and quantitatively compared with prior ex 
vivo and in utero studies, and with observations report-
ed in gestational age-equivalent preterm infants. The 
atlas correctly detected the early presence of limbic 
fiber bundles followed by the appearance and matura-
tion of projection and association fiber bundles (charac-
terized by an age-related increase in fractal anisotropy) 
during late 2nd and early 3rd trimesters and the appear-
ance and maturation of projection throughout gestation. 
During the 3rd trimester association fiber bundles be-
come evident. In parallel with the appearance and matu-
ration of fiber bundles, from 21 to 39 gestational weeks 
a gradual disappearance of the radial coherence of the 
telencephalic wall was qualitatively identified The results 
presented confirm previous advanced fetal connectome 
imaging studies indicating increased vulnerability of the 
human brain during late gestation for pathologies that 
might lead to impaired connectome development and 
subsequently interfere with the development of neural 
substrates serving higher cognition. 
The atlas complements previous initiatives includ-
ing recent development of detailed atlases of the fetal 
(Wright et al., 2015) and neonatal (Makropoulos et al., 
2016) brain that allow robust automated or semi-
automated segmentation of brain regions (Makropoulos 
et al., 2014) and precise delineation of cortical sulcal and 
gyral development (Garcia et al., 2018). Together, all 
these tools allow characterization of the normal trajec-
tories of fetal brain growth and creation of population 
centile charts (https://www.developingbrain.co.uk
/fetalcentiles/ [Gousias et al., 2013]). Comparison with 
these typically developing growth charts therefore pro-
vides an ideal approach with which to assess, quantify, 
and identify deviations in regional and whole brain vol-
umes and also in the ontogenesis, architecture, and 
temporal dynamics of the human brain connectome, and 
would lead to a more precise understanding of the etio-
logical background of neurodevelopmental and mental 
disorders. These tools can be used as a reference for 
DTI-based studies on in utero fetal brain development, 
for groupwise DTI studies to investigate normal and 
abnormal brain development and to enable multi-
modality imaging and computer-aided diagnosis from in 
utero DTIs. 
All these works certainly highlight the significant 
progresses we have made. However, a lack of specificity 
between MRI signal and neuropathological substrate is 
reported, as illustrated recently in one study showing 
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that fractional anisotropy (FA) correlated with astrocyte 
density, a cell type typically not considered in MRI stud-
ies (Stolp et al., 2018). This indicates that the anatomical 
and histological significance of many “signals” in the 
brain remain to be investigated and further studies are 
needed to determine the precise cellular and molecular 
substrates of abnormal connectivity and gray matter 
microstructure observed on MRI. The new methods of 
three-dimensional (3D) multiscale histological imaging 
developed in the last years, including CLARITY (Chung & 
Deisseroth, 2013), MAP (Ku et al., 2016) or SHIELD (Park 
et al., 2018), enable rapid identification of multi-scale 
functional networks and interrogation of their system-
wide, multifactorial interactions and thus, may help in 
the future for integrative and comprehensive under-
standing of large-scale complex biological systems. 
2. Predictive value of childhood neu-
roimaging 
As discussed, in utero MRI detects fetal brain ab-
normalities more accurately than ultrasonography and 
provides additional clinical information in around half of 
pregnancies. However, it is less accurate when used to 
predict abnormal developmental outcome, although still 
better than ultrasonography as shown by Hart and col-
leagues (Hart et al., 2020). In their work published in 
Lancet Child and Adolescent Health, they studied the 
ability of in utero MRI to predict developmental out-
come and whether performing postnatal neuroimaging 
after age 6 months changes its diagnostic accuracy. The 
study was performed in a cohort of children assessed 
with the Bayley Scales of Infant and Toddler Develop-
ment, the Ages and Stages Questionnaire, or both and 
contrasted with ultrasonography findings. Participants' 
development was categorized as normal, at risk, or ab-
normal. However, the authors did not find statistically 
significant differences in infants with abnormal out-
come. The authors suggest that although in utero MRI 
remains the optimal tool to identify fetal brain abnor-
malities, it is not accurate in predicting developmental 
outcome (Hart et al., 2020). 
Further work is needed to determine how the 
prognostic abilities of in utero MRI can be improved to 
identify putative infant brain markers that might be 
associated with neurodevelopmental disorders (Batalle 
et al., 2018). Instead, some works suggest that mapping 
the neurodevelopmental trajectories in childhood has 
the potential to enhance the early identification of risk. 
Whitfield-Gabrieli and colleagues analyzed the data from 
a longitudinal study of 94 children, who underwent rest-
ing-state functional MRI scans at ages 7 and 11 (Whit-
field-Gabrieli et al., 2019). They explored how specific 
patterns of brain resting state functional connectivity 
change during typical development, and how these 
changes related to behavior. The interesting feature of 
this study is that children were initially recruited as typi-
cally developing, but some began to exhibit clinical 
symptoms over time. The aim of the study was to identi-
fy predictors of anxiety and depression behaviors in 
children with no familiar risk for these disorders. 
Specifically, the authors explored whether dysregu-
lated top-down control mechanisms can be detected 
even before behavioral symptoms are evident and can 
predict individual children’s trajectories of attentional 
and internalizing problems, given that in adults with 
depression, anxiety, and ADHD a number of studies have 
shown attenuation or failure of top-down control. The 
strength of coupling between regions involved in top-
down control and their targets can be measured with 
resting-state functional magnetic resonance imaging (rs-
fMRI; Liu et al., 2018; Finn et al., 2015) and reliably char-
acterizes the functional organization of the brain at a 
systems level (Castellanos et al., 2013). The authors 
focused on functional connectivity involving the Default 
Mode Network (DMN), a resting-state network associat-
ed with internal mentation and self-referential pro-
cessing, whose key nodes include the medial prefrontal 
cortex (MPFC). In neurotypical adults, the DMN is nega-
tively correlated (i.e., anticorrelated) with the Central 
Executive Network (CEN; Fox et al., 2005), associated 
with externally focused attention and goal-directed 
behavior, of which the dorsolateral prefrontal cortex 
(DLPFC) is a key node. The magnitude of the anticorrela-
tions between the MPFC and the DLPFC is significantly 
correlated with superior cognitive performance such as 
working memory capacity (e.g., Hampson et al., 2010; 
Keller et al., 2015). In typically developing children, the 
magnitude of anticorrelations between the MPFC and 
DLPFC increases with age along with the improvement of 
top-down control mechanisms. In their study Whitfield-
Gabrieli and colleagues detected individual differences 
in functional connectivity of the DLPFC that predicted 
subsequent appearance of symptoms associated with 
ADHD and depression. Specifically, weaker positive func-
tional connectivity between the DLPFC and the MPFC at 
age 7 was associated with a decrease in ADHD symp-
toms by age 11, whereas weaker positive functional 
connectivity between the DLPFC and the subgenual 
anterior cingulate cortex was associated with an in-
crease in mood-related symptoms by age 11. In fact, 
brain connectivity at age 7 predicted mood-related diffi-
culties at age 11 better than baseline clinical symptoms 
themselves. A limitation of the work is the lack of infor-
mation about which children eventually developed psy-
chiatric disorders in this sample later on. However, these 
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results suggest the potential utility of connectivity pat-
terns as a biomarker of symptom trajectories. 
3. The neurodevelopmental neuropa-
thology of schizophrenia 
During the last year studies performed in humans 
have provided clear evidence that mental disorders such 
as schizophrenia have a strong developmental compo-
nent that might be identified by specific neuropathologi-
cal components. Earlier neuroimaging works reported 
gray matter deficits in schizophrenic patients, mostly 
localized in frontal and temporal lobes, which are pre-
sent prior to the onset of psychosis and worsen during 
the first few years of illness (Glahn et al., 2008). More 
recently, widespread white matter decline was shown in 
whole-brain MRI of schizophrenia patients, identifying it 
as a dysconnectivity syndrome, instead of just a cortical 
lesion syndrome (Fornito et al., 2015). Several theories 
of schizophrenia suggest that structural white matter 
pathologies may follow developmental (McGrath et al., 
2003; Murray et al., 2017), maturational (van Haren et 
al., 2008; French et al., 2015), and/or degenerative 
(Cropley et al., 2017) trajectories. 
Cetin-Karayumak et al. (Cetin-Karayumak et al., 
2019) have addressed this question and also studied 
whether structural white matter pathologies vary among 
fiber tracts across the brain. To this aim they analyzed 
the largest sample of harmonized diffusion MRI data to 
comprehensively characterize age-related white matter 
neuropathology, as measured by FA. The analysis com-
prised diffusion scans of 600 schizophrenia patients and 
492 healthy controls at different illness stages and ages 
(14–65 years), gathered from 13 sites. The authors cross-
sectionally determined the pattern of age-related FA 
changes associated with schizophrenia. In whole-brain 
white matter, FA was up to 7% lower across the lifespan 
and reached peak maturation earlier in patients (27 
years) than controls (33 years), and three distinct pat-
terns of neuropathology could be identified. They de-
tected tract-specific early developmental abnormalities 
in limbic fibers that do not progress over time, suggest-
ing that limbic connections are selectively vulnerable to 
early developmental anomalies. Instead, long-range 
intra-hemispheric association tracts (including language 
tracts) displayed abnormal maturation with shorter 
maturational windows and faster declines consistent 
with accelerated ageing processes in schizophrenia. 
Finally, the authors report accelerated aging in callosal 
fibers that exhibited severe deficits from the outset of 
illness, which became more pronounced with increasing 
age (reaching a 10% reduction after sixth decade). This 
reduced anisotropy of the corpus callosum is a well-
replicated diffusion imaging finding in schizophrenia, 
consistent across heterogeneous patient populations 
and maturational phases. 
The study makes a timely and important contribu-
tion to the field showing that white matter neuropathol-
ogy in schizophrenia involves lifelong dynamic tract-
specific changes. The findings support a developmental 
perspective, suggesting that widely distributed white 
matter deficits emerge early or display perturbed matu-
ration. In addition, callosal and long-range association 
(but not limbic) fibers undergo accelerated aging pro-
cesses. This work provides an initial benchmark for tract-
specific trajectories of white matter abnormalities. 
4. Disease-in-a-dish developmental 
neuropathology 
In recent years there has been a growing emphasis 
on developing patient-specific cellular models that can 
be manipulated by the experimenter to understanding 
the role of different factors in shaping individual brain 
development and functioning. Human pluripotent stem 
cells (hPSCs), including human embryonic stem cells 
(hESCs) and human induced pluripotent stem cells (hiP-
SCs), have been revealed as invaluable tools for model-
ing human disorders, especially those with complex 
genetic origins (Takahashi et al., 2007; Takahashi & Ya-
manaka, 2006). hPSCs have the potential to differentiate 
into any cell or tissue type. Induced pluripotent stem 
cells (iPSCs) reprogrammed from patient somatic cells 
also offer an opportunity to recapitulate disease devel-
opment in relevant cell types, and they provide novel 
approaches for understanding disease mechanisms. 
Stem cells can be used to generate organoids, or-
gan-like 3D tissue cultures containing multiple cell types 
that represent accessible systems for modeling organo-
genesis and developmental disorders (Lyon, 2019). 
hPSC-derived brain organoids self-assemble to form an 
organized architecture, composed of progenitor, neu-
ronal and glial cell types, resembling the fetal human 
brain (Jo et al., 2016; Kadoshima et al., 2017; Lancaster 
et al., 2013).  Until recently, these in vitro systems had 
strong limitations. First, organoids develop without the 
presence of normal embryonic surrounding thus lacking 
the developmental and patterning cues, which are es-
sential for organ development. Additionally, most proto-
cols depend on the ability of stem cells to self-organize 
into distinct brain structures which can cause incon-
sistency in producing the desired tissues, resulting in 
heterogeneity or “batch-effects” in different batches of 
organoids, which can vary in quality and brain regions 
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they generate, making it difficult to identify real pheno-
types. Human brain organoids are prone to high organ-
oid-to-organoid variability (Quadrato et al., 2016; Yoon 
et al., 2019; Grenier et al., 2020). Furthermore, the ab-
sence of vascularization is probably responsible for the 
shortage of progenitor populations, making it difficult to 
replicate cortical plate formation. All of this has raised 
doubts as to whether developmental processes of the 
human brain can occur outside the context of embryo-
genesis with a degree of reproducibility that is compara-
ble to the endogenous tissue (Jabaudon & Lancaster, 
2018). 
The last years have been exciting for the field, be-
cause some of these limitations are starting to be over-
come. Recently, Mansour et al. (Mansour et al., 2018) 
showed that intracerebral transplantation of brain or-
ganoids in mice results in impressive growth of blood 
vessels into the human tissue, with clear benefits for cell 
survival and maturation compared with organoids kept 
in vitro. Also, Real and colleagues (Real et al., 2018) have 
shown the potential of these methods to model human 
neuropathology. They transplanted human iPSC-derived 
cortical neurons from two persons with Down syndrome 
into the adult mouse cortex and observed that those 
consistently organized into large (up to ~100 mm3) vas-
cularized neuron-glia territories. Down syndrome trans-
plants showed increased synaptic stability and reduced 
oscillations, thus recapitulating in part the patients’ 
phenotypes. Finally Velasco and colleagues (Velasco et 
al., 2019) showed that an organoid model of the dorsal 
forebrain can reliably generate a rich diversity of cell 
types appropriate for the human cerebral cortex. Using 
single-cell RNA-sequencing analysis of 166,242 cells 
isolated from 21 individual organoids, the authors show 
that the organoid-to-organoid variability is comparable 
to that of individual endogenous brains, and 95% of the 
organoids derived from different stem cell lines generate 
a virtually indistinguishable compendium of cell types, 
showing consistent reproducibility in the cell types pro-
duced. The authors thus demonstrated that establish-
ment of terminal cell identity is a highly constrained 
process and that reproducible developmental trajecto-
ries of cellular diversity of the CNS does not require the 
context of the embryo. 
5. Growing networks in a dish 
Most of the current organoid protocols or medium 
formulations favor progenitor cells, thus not enabling 
them to mature and mimic some aspects of the human 
brain development such as dynamic changes in cellular 
populations during maturation or the formation of long-
range connectivity. 
In a recent work, Trujillo and colleagues (Trujillo et 
al., 2019) developed cortical organoids that spontane-
ously displayed periodic and regular oscillatory network 
events that are dependent on glutamatergic and γ-
aminobutyric acid (GABA)-ergic signaling. They could 
record consistent increases in electrical activity over the 
span of several months reflecting the formation of a 
spontaneous network that displayed periodic and regu-
lar oscillatory events. These nested oscillations exhibited 
cross-frequency coupling, subsequently transitioning to 
more spatiotemporally irregular patterns, resembling 
features observed in preterm human electroencephalog-
raphy (EEG). These results suggest that the development 
of structured network activity in the human neocortex 
takes place even in the absence of external or subcorti-
cal inputs, and open opportunities for investigating and 
manipulating the role of network activity in the develop-
ing human cortex. 
Two independent groups (Cullen et al., 2019; Kiri-
hara et al., 2019) have developed a human stem cell-
derived model of cerebral tracts and have described the 
phenotype and connectivity of constrained 3D human 
axon tracts derived from brain organoids. In the work of 
Kirihara and colleagues they used a microfluidic device, 
in which two spheroids of cortical neurons derived from 
hiPSCs extended axons into a microchannel between the 
spheroids and spontaneously formed an axon fascicle, 
mimicking a cortico-cortical tract that connected the two 
spheroids reciprocally. The axon fascicle was able to 
communicate electrically between the spheroids with 
distinct response kinetics. This cerebral tract model 
should provide a promising platform to study the mech-
anisms underlying cerebral tract development and relat-
ed diseases. Using their model of cerebral tracts, the 
authors could recapitulate the agenesis of corpus callo-
sum (Edwards et al., 2014), by knocking down L1CAM 
gene (Demyanenko et al., 1999; Siegenthaler et al., 
2015) in the spheroids. Axons from the L1CAM knock-
down cells exhibited significantly lower ratio of axons 
assembled into a bundle than the control cells, suggest-
ing that this method can be used to model developmen-
tal disease related to cerebral tracts. 
Microfluidic devices, involving a two-compartment 
system connected by narrow grooves, have also been 
used to reconstruct dentate gyrus (DG)–Cornu Ammonis 
area 3 (CA3) circuitry in which DG neurons are cultured 
in one compartment and CA3 neurons are cultured in 
the other compartment (Sarkar et al., 2018). In this sys-
tem, axonal growth is allowed through the narrow 
grooves connecting the two compartments whereas cell 
migration is restricted. Rabies virus infection of the CA3 
neurons permits the detection of presynaptic neurons 
that monosynaptically connect to the postsynaptic CA3 
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neurons. These engineered neural tissue connectivity 
models represent a first step toward potentially recon-
structing brain circuits by physically replacing neuronal 
populations and long-range axon tracts in the brain, and 
might reveal how long-range connections are altered in 
the brains of people with neurodevelopmental disor-
ders. 
6. Genes involved in early cortical pat-
terning are at the heart of mental 
comorbidity 
Over the past decade, genetic studies have been 
quite successful at identifying rare genetic variations, 
including inherited and de novo mutations and copy 
number variations (CNVs), related to specific develop-
mental disorders. However, evidence is mounting to 
suggest that genetic risk variants identified among indi-
viduals with different brain disorders may converge on 
common genetic pathways. The remarkably complex 
architecture that embraces genetic mutations of distinct 
types (chromosomal rearrangements, copy number 
variants, small indels, and nucleotide substitutions) with 
distinct frequencies in the population (common, rare, de 
novo) creates difficulties in establishing rigorous geno-
type-phenotype correlations (Cardoso et al., 2019). 
Moreover, the cumulative effect of multiple common 
genetic variants, i.e., polygenic risk, is now being recog-
nized as an important indicator of neurodevelopmental 
and psychiatric disorders (Cross-Disorder Group of the 
Psychiatric Genomics Consortium, 2013). Large-scale 
genome-wide ASD and cross-disorder association studies 
with enough statistical power to estimate small effects 
from common genetic variants are only now emerging, 
and they require combining data sets from multiple, 
large population samples. 
This need has been long recognized as testified by 
initiatives such as the Psychiatric Genomics Consortium 
(PGC), the largest consortium in the history of psychiatry 
(Sullivan et al., 2018). Now, in the largest-ever study of 
its kind, published in Cell, Lee et al. (Cross-Disorder 
Group of the Psychiatric Genomics Consortium, 2019) 
identified more than 100 genetic variants that affect the 
risk for more than one mental health condition, indicat-
ing that distinct psychiatric diseases share a common 
genetic structure, as shown. Using genome-wide associ-
ation to analyze genetic data from 494,162 healthy con-
trols and 232,964 individuals diagnosed with at least one 
of eight common psychiatric disorders, the researchers 
identified 109 gene variants that affect the risk for more 
than one psychiatric disorder. Certain disorders shared 
many variants, allowing the researchers to divide the 
conditions into three groups of genetically-related con-
ditions: disorders characterized by compulsive behaviors 
(anorexia nervosa, obsessive-compulsive disorder and, 
to a lesser extent, Tourette syndrome); mood and psy-
chotic disorders (bipolar disorder, major depression and 
schizophrenia); and early-onset neurodevelopmental 
disorders (ASD, ADHD and Tourette syndrome). Im-
portantly, genes associated with multiple disorders 
showed increased expression beginning in the second 
trimester of pregnancy and play an important role in 
brain development. 
Another research team has found the first com-
mon genetic risk variants for autism robustly associated 
with ASD (Grove et al., 2019) in a genome-wide associa-
tion meta-analysis carried out in a Danish population 
resource of 18,381 individuals with ASD and 27,969 
controls. The meta-analysis identified five genome-wide-
significant loci. Moreover, the study identified several 
ASD gene variants that had especially widespread influ-
ence on the risk for a number of psychiatric disorders. 
Concretely, the authors report seven loci shared with 
other traits, obtained by combining the dataset with 
genome-wide association study (GWAS) results from 
phenotypes with significantly overlapping genetic archi-
tectures (schizophrenia, major depression, and educa-
tional attainment). The researchers also uncovered, for 
the first time, genetic differences between the different 
clinical subgroups of autism. This will pinpoint genes that 
separate the diagnostic groups and enable more precise 
diagnosis, and could orient the search for behavioral, 
imaging and electrophysiological markers of atypical 
development in the infant brain. 
These genetic findings provide an entirely new in-
sight into the cross-disorder biological processes, partic-
ularly relating to neuronal function and corticogenesis, 
and help to triangulate on families of genes active during 
early cortical patterning (Morgan et al., 2019; Figure 1), 
associated with the establishment and maintenance of 
neuronal connectivity (Parikshak et al., 2015) or with the 
foundation of inhibitory/excitatory balance in early 
childhood (Marin, 2012). 
7. Mechanistic role of RNA editing in 
schizophrenia and autism neuropa-
thology 
We have progressively realized in recent years that 
the molecular neuropathology landscape of brain disor-
ders is much more complex than anticipated and new 
players, such as epigenetic regulation, alternative splic-
ing, post-transcriptional and -translational modifications, 
and somatic mosaicism of DNA, not only in protein-
Free Neuropathology 1:13 (2020) Mara Dierssen 
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Figure 1. Left panel: Large-cohort genome-wide studies are allowing to triangulate families of genes involved in early brain maldevel-
opment. Middle: Early cortical patterning is at the heart of mental comorbidity. The advances in single-cell omics will help understand 
the pathogenesis of developmental lesions. Right panel: Critical steps of brain connectivity development have possible links to in utero 
MRI-detectable phenomena. For example, emergence of long-range connectivity may be detected by in-utero diffusion tensor tractog-
raphy as increasing integration demonstrated using whole-brain diffusion tractography. 
 
 
coding sequences but also in large non-coding regions, 
contribute to developmental neuropathology. Tran-
scriptomic analyses of postmortem brains have begun to 
elucidate some of these new mechanisms in ASD and 
schizophrenia. However, a crucial pathway involved in 
synaptic development and neuronal function, RNA edit-
ing, has not yet been studied on a genome-wide scale. 
RNA editing is a major RNA processing mechanism, 
which refers to the alteration of RNA sequences through 
insertion, deletion or substitution of nucleotides. It is 
thought to constitute one of the molecular mechanisms 
connecting environmental stimuli and behavioral out-
puts (Lapp & Hunter, 2019). Adenosine to inosine (A-to-
I) editing is the most common form of RNA editing (Mal-
lela & Nishikura, 2012; Figure 2), affecting the majority 
of human genes, and is highly prevalent in the brain 
(Liscovitch et al., 2014; Suarez et al., 2018). Editing sites 
in coding regions can be conserved across species and 
are commonly located in genes involved in neuronal 
function. Site-specific A-to-I RNA base conversions, car-
ried out by adenosine deaminase acting on RNA (ADAR) 
enzymes, exhibit precise regional specificity in the brain 
and modulate complex behavior in model organisms. 
Examples of transcripts edited by ADAR are mRNAs en-
coding glutamate receptors, serotonin receptors, and 
potassium channels and other neuronal signaling func-
tions in the CNS (Rosenthal & Seeburg, 2012; Meier et 
al., 2016; Streit & Decher, 2011). These sites are tightly 
and dynamically regulated throughout pre- and post-
natal human cortical development (Figure 2). Most edit
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Figure 2. Elevated ADAR2 expression in neuronal nuclei increases A-to-I RNA editing during neuronal maturation. Left panel: ADAR 
enzyme acting on double-stranded RNA. ADAR RNA-binding domains act on RNA binding sites and convert adenine to inosine. Right 
panel: As neurons mature, A-to-I RNA editing increases gradually together with expression of importin-a4. As a result, ADAR is elevated 
in the nucleus leading to increased A-to-I RNA editing in mature neurons. Credits: Ilario De Toma, adapted from Behm et al., 2017 and 
Lorenzini et al., 2018. 
 
 
ing sites reside in non-coding regions, and particularly 
within sequences called transposons via RNA intermedi-
ates (retrotransposons, see below) with a possible path-
ophysiological role (Krestel & Meier, 2018). Aberrant 
RNA editing has been reported in several neurological 
disorders, including major depression, Alzheimer’s dis-
ease, and amyotrophic lateral sclerosis. 
In ASD, recent studies in postmortem samples have 
revealed transcriptome dysregulation affecting neuronal 
and glial coding and non-coding gene expression, neu-
ronal splicing including microexons, and microRNA tar-
geting (Irimia et al., 2014; Salloum-Asfar et al., 2019; 
Gandal et al., 2018). Tran et al. (Tran et al., 2019) have 
now tested the largest cohort of post-mortem ASD brain 
samples, spanning multiple brain regions for abnormali-
ties in RNA editing. A previous study had analyzed a few 
known RNA editing sites in synaptic genes and reported 
altered editing patterns in a small cohort of ASD cerebel-
la (Eran et al., 2013), but it was not known whether 
global patterns of RNA editing contributed to the neuro-
pathology of ASD. Now Tran and colleagues report glob-
al patterns of dysregulated RNA editing, with hypoedit-
ing across brain regions and involving many synaptic 
genes in ASD brains.  The set of genes harboring at least 
one differential editing site in frontal cortex exhibited 
significant gene ontology (GO) enrichment for ionotropic 
glutamate receptor activity, glutamate gated ion channel 
activity, and synaptic transmission. The authors also 
identified a core set of down-regulated RNA editing 
sites, enriched in ASD susceptibility genes. Interestingly, 
a set of these hypoedited sites are related to Fragile X 
syndrome (FXS) proteins. Concretely, FMRP and FXR1P 
interact with ADAR and modulate A-to-I editing. The 
authors detected convergent dysregulated patterns of 
RNA editing in FXS and ASD patients, consistent with the 
findings that genes harboring ASD risk mutations are 
enriched in FMRP targets. Their findings were corrobo-
rated across multiple datasets, including dup15q cases 
associated with intellectual disability. 
Regarding schizophrenia, Breen and colleagues 
(Breen et al., 2019) have analyzed the global landscape 
and genetic regulation of RNA editing across several 
hundred schizophrenia and control postmortem brain 
samples from the dorsolateral prefrontal cortex and 
anterior cingulate cortex. In schizophrenia, RNA editing 
sites in genes encoding AMPA-type glutamate receptors 
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and postsynaptic density proteins were less edited, 
whereas those encoding translation initiation machinery 
were more edited. These findings were cross-validated 
in hundreds of non-overlapping dorsolateral prefrontal 
cortex samples. Furthermore, ~30% of RNA editing sites 
associate with cis-regulatory variants (editing quantita-
tive trait loci or edQTLs). Fine-mapping edQTLs with 
schizophrenia risk loci revealed co-localization of eleven 
edQTLs with six GWAS loci. The findings demonstrate 
widespread altered RNA editing in schizophrenia and its 
genetic regulation, and suggest a causal and mechanistic 
role of RNA editing in schizophrenia neuropathology. 
Overall, both papers provide global insights regarding 
RNA editing in ASD and schizophrenia pathogenesis and 
reveal novel mechanisms underlying these disorders. 
8. Incomplete silencing of full muta-
tion alleles in males with fragile X 
syndrome is associated with autistic 
features 
The paper by Tran et al. (Tran et al., 2019) convinc-
ingly demonstrated that RNA editing acts as a molecular 
link between FXS and ASD. FXS is caused by loss of the 
FMR1 product (FMRP), but also by mosaicism for active 
and inactive FMR1 alleles, including alleles termed 
premutation (55–199 CGGs). Importantly, both premuta-
tion and active full mutation (≥ 200 CGGs) alleles often 
express elevated levels of mRNA that are thought to be 
toxic. 
Two studies published in 2019 report that incom-
plete silencing of toxic full mutation RNA may be associ-
ated with autistic features in FXS males. Baker and col-
leagues (Baker et al., 2019) studied whether complete 
FMR1 mRNA silencing from full mutation alleles and/or 
levels of FMR1 mRNA (if present) in blood were associ-
ated with intellectual functioning and autism features in 
FXS. The study cohort included 98 participants (70.4% 
male) with FXS (full mutation-only and mosaic). FMR1 
mRNA was analyzed against control FMR1 mRNA and 
correlated with intellectual disability and autistic fea-
tures. FMR1 was completely turned off in some of the 
patients, while it was partially turned on in the majority 
of participants. Females with FXS had significantly higher 
levels of FMR1 mRNA that were not associated with 
intellectual functioning nor autistic features. In FXS 
males decreased levels of FMR1 mRNA were associated 
with decreased intellectual functioning, but not autism 
features. The authors show for the first time that people 
with a partially turned-on FMR1 had intellectual disabil-
ity and more traits of ASD, whereas people with the 
gene completely turned off had intellectual disability 
and much less severe autism. The authors conclude that 
abnormally elevated levels of FMR1 mRNA may lead to 
FMR1 mRNA-related cellular “toxicity”. These findings 
may explain why severity of Fragile X is not the same 
between affected individuals. 
Based on this study, some months later Field et al. 
(Field et al., 2019) described the case of two young 
brothers with expanded FMR1 alleles, who were ‘high 
functioning’. The two brothers presented autistic fea-
tures and language delay, but a higher non-verbal IQ in 
comparison to typical FXS. Both had low-level methyla-
tion mosaicism not detected by standard testing in 
blood, and their FMR1 mRNA levels were increased ~5-
fold compared to typical developing controls, and signif-
icantly above the levels reported from Baker’s study 
described above. The authors speculate that the active 
unmethylated full mutation and/or premutation alleles 
lead to the expression of toxic expanded mRNA in some 
cells, in conjunction with possible reduced FMR1 mRNA 
and FMRP levels in other cells with FMR1 methylation. 
Both mechanisms may contribute to the elevated ASD 
symptoms. This hypothesis is also in line with the find-
ings reported by Baker et al. showing that males who 
expressed full mutation FMR1 mRNA, had significantly 
more severe ASD symptoms compared to males who 
had completely silenced FMR1. 
9. Transposable elements in neurode-
velopmental disorders 
Transposable elements (TEs) constitute about half 
of the human genome and are becoming increasingly 
important to the field of neuroscience as their roles in 
mammalian development, immune response, and con-
tributions to behavioral and cognitive domains continue 
to be uncovered (International Human Genome Se-
quencing Consortium, 2001; Nandi et al., 2016). Trans-
posons are mobile DNA elements present in virtually all 
eukaryotes that can replicate and mobilize from one 
chromosomal loci to another through either a DNA or 
RNA intermediate (Levin & Moran, 2011). 
Retrotransposons are often called ‘jumping genes’, 
because the messenger RNA transcribed from them can 
undergo a process called reverse transcription to pro-
duce an identical DNA sequence that then reinserts into 
the genome at a different site. They parallel viruses in 
many ways in their structure and function, as they en-
sure their own survival by way of reintegration. Their 
propensity to self-propagate has a myriad of conse-
quences and yet their biological significance is not well-
understood. Although retrotransposons comprise about 
42% of the human genome, most carry mutations that 
render them functionally inactive (Cordaux & Batzer, 
2009). Retrotransposons are emerging as potent regula-
Free Neuropathology 1:13 (2020) Mara Dierssen 
doi: https://doi.org/10.17879/freeneuropathology-2020-2672 page 11 of 16 
    
 
 
tory elements within the human genome. Transcription 
of those that remain functional must be prevented by 
protein- or RNA-based regulatory mechanisms to pre-
vent the jumping of retrotransposons, which can cause 
either genetic mutations or genomic instability and 
might lead to cancer (Scott & Devine, 2017). Moreover, 
retrotransposons can be reactivated during ageing (De 
Cecco et al., 2013). 
Human Endogenous Retroviruses (HERV) and Long-
Interspersed Nuclear Element-1 (LINE-1) are two main 
classes of retrotransposons, mobilized through a “copy 
and paste” mechanism. LINE-1 somatic retrotransposi-
tion has been well-demonstrated to occur in neuronal 
lineage, however the significance of retroelement activi-
ty to normal brain function remains uncertain. Further-
more, the contribution of these endogenous retroele-
ments to the etiopathogenesis of neurodevelopmental 
disorders is a topic of recent exploration. Roughly 130 
pathogenic variants caused by retrotransposon activity 
have been documented, but the majority of these dele-
terious events are isolated cases. As such, they are not 
part of routine clinical sequencing, and thus represent a 
largely unassessed category of genetic variation in many 
disorders. Human-specific LINE-1 (L1Hs) is the most 
active autonomous retrotransposon family in the human 
genome. Mounting evidence supports that L1Hs re-
trotransposition occurs postzygotically in the human 
brain cells, contributing to neuronal genomic diversity. 
In a paper in 2018 Jacob-Hirsch et al. (Jacob-Hirsch 
et al., 2018) already reported that the number of re-
trotranspositions is higher in brain tissues than that in 
non-brain samples and even higher in pathologic vs. 
normal brains. Their findings documented that L1Hs 
elements integrate preferentially into genes associated 
with neural functions and diseases. The authors propose 
that pre-existing retrotransposons act as “lightning rods” 
for novel insertions, which may safeguard from deleteri-
ous events and thus, uncontrolled retrotransposition 
may breach this safeguard and increase the risk of harm-
ful mutagenesis in neurodevelopmental disorders. Zhao 
and colleagues (Zhao et al., 2019) profiled genome-wide 
L1Hs insertions among 20 postmortem tissues from Rett 
patients and matched controls. They identified and vali-
dated somatic L1Hs insertions in both cortical neurons 
and non-brain tissues, with a higher jumping activity in 
the brain and concluded that MeCP2 dysfunction might 
alter the genomic pattern of somatic L1Hs in Rett pa-
tients. Now Gardner et al. (Gardner et al., 2019) have 
identified retrotransposition-derived events in 9738 
exome sequenced trios with developmental-affected 
probands. They encountered 9 de novo retrotranspos-
ons and 2 de novo gene retro-duplications. From those, 
4 transposons were the likely cause of the symptoms of 
four patients, three of whom had not had previous diag-
noses. These studies open a possibility of “diagnostic 
retrotransposition events” and are another step along 
the path to understanding the causes of developmental 
disorders. 
10. Single-cell genomics identifies cell 
type–specific molecular changes in 
autism 
I have presented several efforts and advances to 
disentangle important elements in the molecular neuro-
pathology of neurodevelopmental disorders. One limita-
tion, however, is that most postmortem studies apply 
bulk omic approximations to a complex tissue, the brain, 
in which diverse human cells may contribute differently 
to neurodevelopmental disorders. In ASD, for example, 
previous bulk gene expression studies identified com-
mon genes and pathways dysregulated in the neocortex 
of autism patients that did not explain its clinical and 
genetic heterogeneity. Direct assessment of specific cell 
types in the brain affected by neurodevelopmental dis-
orders has not been feasible until recent advances in 
techniques for isolating thousands of intact cells and 
efficiently sequencing each of them. Single-cell RNA-
sequencing (scRNA-seq) has evolved over the past few 
years as a high-throughput method for transcriptome 
profiling of thousands of cells (Tasic, 2018) and has iden-
tified diverse cell types in many brain regions, including 
neocortex (Tasic et al., 2018), hypothalamus (Campbell 
et al., 2017), and retina (Shekhar et al., 2016). This will 
allow scientists to explore neurodevelopmental neuro-
pathology at a resolution that was not possible before. 
An international consortium called the Human Cell Atlas 
(https://www.humancellatlas.org/) is an effort to identi-
fy every human cell type, where each type is located in 
the body, and how the cells work together to form tis-
sues and organs. Another effort, a collaboration of 53 
institutions and 60 companies across Europe, called the 
LifeTime Initiative (https://lifetime-fetflagship.eu/), is 
proposing to harness single-cell technologies to under-
stand what happens cell by cell as tissues progress to-
ward diseases. 
Transcriptomic profiling of complex tissues by 
scRNA-seq has unfortunately also limitations, the most 
important being that neurons, being complex arborizing 
cells, are vulnerable to mechanical dissociation and 
sorting. This makes scRNA-seq hard to apply to adult 
brain tissue to tease out individual cells from the elabo-
rately tangled circuitry of the brain. 
Few studies have analyzed neurodevelopmental 
disorders at a single-cell resolution. A turning point 
came last year, when Velmeshev and colleagues 
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(Velmeshev et al., 2019) used newer techniques to ex-
tract RNA from cell nuclei isolated from samples of brain 
tissue and then analyzed signature patterns of gene 
expression of single brain cells, including neurons and 
glia, from patients with autism. Single-nucleus RNA-
sequencing (snRNA-seq) affords some advantages over 
scRNA-seq. In contrast to whole cells, nuclei are more 
resistant to mechanical assaults and can be isolated 
from frozen tissue (Krishnaswami et al., 2016), so that 
snRNA-seq provides less biased cellular coverage than 
scRNA-seq, since it suffers less cell isolation-related 
transcriptional artifacts (some cell types are more vul-
nerable to dissociation process and are thus underrepre-
sented in the final scRNA-seq data set (Lake et al., 
2016)).  Velmeshev et al. applied this single-nuclei se-
quencing approach to snap-frozen post-mortem samples 
of prefrontal cortex and anterior cingulate cortex, two 
brain regions previously shown to be altered in patients 
with autism. snRNA-seq analysis of more than 100,000 
cell nuclei identified a common set of changes in genes 
involved in synaptic communication as well as neural 
outgrowth and migration. Previous studies suggested 
convergence of ASD on specific cell types during fetal 
development (Parikshak et al., 2013; Willsey et al., 
2013). Furthermore, in patient samples, specific sets of 
genes enriched in upper-layer cortico-cortical projection 
neurons and microglia correlated with clinical severity. 
They also found changes in glial cells that could impact 
their role in pruning and maintaining healthy neural 
circuits. Many of the differentially expressed genes are 
known to be widely expressed across the entire brain, 
but they appeared to be significantly altered only in 
projection neurons of ASD. These findings suggest that 
molecular changes in cell types with shared develop-
mental lineages exhibit convergent transcriptional 
changes in adult ASD patients, and that the expression 
of synaptic and neurodevelopmental genes in layer 2/3 
cortical neurons is especially affected. This implies that 
disturbances of gene regulatory programs during devel-
opment cascade into molecular pathology in specific 
mature neural cell types, such as upper-layer projection 
neurons and microglia, which correlate with the clinical 
severity of ASD. 
One limitation of the study is the small cohort size, 
since the authors compared brain samples from only 15 
people with autism and 16 people who died in the same 
age range (4-22 years) of non-neurological causes. Since 
almost half of the patients with autism also suffered 
from seizures, the researchers examined brain samples 
from a cohort of patients with sporadic epilepsy, to iden-
tify brain changes more likely to stem from seizures than 
primary ASD–associated gene expression changes. An-
other general limitation is that, because cells must be 
removed from the brain, single cell omic techniques 
alone do not reflect how those cells interact with their 
neighbors or circuit level changes. Future studies involv-
ing larger patient cohorts, including whole-exome se-
quencing and improved single-cell technologies, are 
needed to allow for precise identification of ASD-driven 
changes and their association with genetic variants. The 
authors provide an interactive web browser to interro-
gate their transcriptomic data: https://autism.cells.
ucsc.edu. 
Colophon 
Neurodevelopmental disorders are inherently 
complex, involving multiple components of an intricate 
network. The multi-dimensional nature of the develop-
mental disorders suggests that no unifying “cause” but 
instead multi-level perturbation causes complex neuro-
developmental disorders with a host of systemic comor-
bidities and striking heterogeneity. Many research 
groups are still trying to decipher the genomic complexi-
ty of disorders such as autism, and the list of autism 
“risk” genes grows each year. A number of new unex-
pected molecular players such as RNA editing and re-
trotransposons have been identified, and their impact 
on brain development is being examined. Because a 
deep understanding of these underlying mechanisms 
could prove seminal for personalized medicine, re-
searchers have designed new cellular models with rea-
sonable construct face and predictive validity. Of course, 
other factors such as the contribution of individual life-
styles, cannot be dismissed as they are fueling a large 
spectrum of gene-environment interactions that have a 
key role in the genotypes /phenotypes relationships. A 
more thorough understanding of the intricate processes 
underlying normal and abnormal human CNS develop-
ment is needed to answer many fundamental questions 
in biology and medicine and will lead to meaningful 
clinical biomarkers of developmental neuropathology in 
humans. 
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